Structure Therapeutics (GPCR) Change in Account Payables (2022 - 2026)
Quarterly Change in Account Payables fell 824.05% to -$5.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$888000.0 through Mar 2026, down 140.85% year-over-year, with the annual reading at $4.8 million for FY2025, 44.09% up from the prior year.
Structure Therapeutics' Change in Account Payables history spans 5 years, with the latest figure at -$5.0 million for Q1 2026.
- Change in Account Payables came in at -$5.0 million for Q1 2026, up from -$5.0 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $8.8 million in Q3 2025 to a low of -$5.0 million in Q4 2025.
- The 5-year median for Change in Account Payables is $280000.0 (2025), against an average of $258705.9.
- Year-over-year, Change in Account Payables soared 1227.42% in 2023 and then plummeted 1083.69% in 2025.
- Structure Therapeutics' Change in Account Payables stood at -$124000.0 in 2022, then skyrocketed by 1227.42% to $1.4 million in 2023, then crashed by 130.26% to -$423000.0 in 2024, then tumbled by 1083.69% to -$5.0 million in 2025, then grew by 0.8% to -$5.0 million in 2026.
- Per Business Quant, the three most recent readings for GPCR's Change in Account Payables are -$5.0 million (Q1 2026), -$5.0 million (Q4 2025), and $8.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | - |
| 10 | Structure Therapeutics | 8.43 Bn | 8.43 Bn | - | -4.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.97 Mn |
| Mar 31, 2026 | -4.97 Mn |
| Dec 31, 2025 | -5.01 Mn |
| Dec 31, 2025 | -5.01 Mn |
| Sep 30, 2025 | 8.81 Mn |
| Sep 30, 2025 | 8.81 Mn |
| Jun 30, 2025 | 280,000.00 |
| Jun 30, 2025 | 280,000.00 |
| Mar 31, 2025 | 686,000.00 |
| Mar 31, 2025 | 686,000.00 |
| Dec 31, 2024 | -423,000.00 |
| Dec 31, 2024 | -423,000.00 |
| Sep 30, 2024 | 6.30 Mn |
| Sep 30, 2024 | 6.30 Mn |
| Jun 30, 2024 | -4.39 Mn |
| Jun 30, 2024 | -4.39 Mn |
| Mar 31, 2024 | 1.82 Mn |
| Mar 31, 2024 | 1.82 Mn |
| Dec 31, 2023 | 1.40 Mn |
| Dec 31, 2023 | 1.40 Mn |
| Sep 30, 2023 | -2.38 Mn |
| Sep 30, 2023 | -2.38 Mn |
| Jun 30, 2023 | 1.05 Mn |
| Jun 30, 2023 | 1.05 Mn |
| Mar 31, 2023 | -923,000.00 |
| Mar 31, 2023 | -923,000.00 |
| Dec 31, 2022 | -124,000.00 |
| Dec 31, 2022 | -124,000.00 |
| Sep 30, 2022 | 2.27 Mn |
| Sep 30, 2022 | 2.27 Mn |
| Jun 30, 2022 | 1.58 Mn |
| Jun 30, 2022 | 1.58 Mn |
| Mar 31, 2022 | -1.56 Mn |
| Mar 31, 2022 | -1.56 Mn |